Exelixis (EXEL) Stock Insights

EXEL price $66.04 +0.69 +1.06%

Ticker
EXEL
Price
$66.04
Change
+0.69 +1.06%
Market cap ?
$16.60B
P/E ?
19.86
Forward P/E ?
18.53
Dividend yield ?
0.00%
Beta ?
0.42
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
64
Value
42
Quality
94
Growth
55

Stocklytics score rationale: value 42, quality 94, growth 55.

Financials

2016201720182019202020212022202320242025
19145400045247700085382600096777500098753800014349700001611062000183020800021687010002320126000

Exelixis, Inc. operates as a biotechnology firm dedicated to combating cancer, primarily focusing on the identification, advancement, and marketing of novel oncological treatments within the United States. Its portfolio of commercially available therapeutics includes CABOMETYX tablets, prescribed for individuals with advanced renal cell carcinoma who have previously undergone anti-angiogenic treatment, and COMETRIQ…

Fair value

EXEL fair value $106.18. Price $66.04. Price is 38% below fair value.

Below fair value, but more expensive than usual. A smaller discount than on 62% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.16B. Growth 13.28%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 251.36M. Net debt -309.45M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare EXEL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—0.89—646.51M
2026-08-050.910.85628.69M636.40M
2026-05-050.870.77610.81M607.51M
2026-02-100.940.77598.66M596.52M
2025-11-040.780.69597.75M590.16M
2025-07-280.750.65568.26M594.93M
2025-05-130.620.36555.45M499.60M
2025-02-110.550.51566.75M563.21M
2024-10-290.400.35539.54M556.58M
2024-08-060.770.30637.18M465.00M
2024-04-300.170.28425.23M460.62M
2024-02-060.270.21479.65M480.17M
2023-11-010.100.10471.92M471.89M
2023-08-010.250.16469.85M447.63M
2023-05-090.120.15408.79M424.10M
2023-02-07-0.09-0.11423.92M417.61M
2022-11-010.230.19411.74M403.47M
2022-08-090.220.19419.43M391.03M
2022-05-100.210.14355.98M374.45M
2022-02-170.290.06451.14M355.78M
2021-11-020.120.17328.42M345.73M
2021-08-050.300.06385.18M295.49M
2021-05-060.00—270.23M263.42M
2021-02-100.090.05270.05M200.51M
2020-11-05-0.10-0.05231.09M23.11M
2020-08-060.210.12259.48M240.83M
2020-05-050.150.13226.91M196.66M
2020-02-250.220.17240.31M185.69M
2019-10-300.310.19271.70M166.53M
2019-07-310.250.23240.28M221.05M
2019-05-010.240.23215.49M206.51M
2019-02-120.370.25228.60M45.72M
2018-11-010.410.19225.40M198.19M
2018-08-010.280.16186.11M172.73M
2018-05-020.370.16212.35M164.24M
2018-02-260.120.12120.07M452.48M
2017-11-010.260.08152.51M46.93M
2017-08-020.060.0499.01M66.01M
2017-05-010.050.0180.89M16.18M
2017-02-270.120.0177.58M6.47M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-10Beckerle Mary CSell9.81K$53.66526.51K
2026-06-01WYSZOMIERSKI JACK LSell3.92K$50.55198.41K
2026-06-01Eckhardt Sue GailSell9.81K$50.14491.97K
2026-05-27PAPADOPOULOS STELIOSBuy8.37K——
2026-05-27Heyman Tomas J.Buy8.37K——
2026-05-27Eckhardt Sue GailBuy8.37K——
2026-05-27Smith JulieBuy8.37K——
2026-05-27Freire Maria CBuy8.37K——
2026-05-27Beckerle Mary CBuy8.37K——
2026-05-27Oliver BobBuy8.37K——
2026-05-27WYSZOMIERSKI JACK LBuy8.37K——
2026-05-27POSTE GEORGEBuy8.37K——
2026-05-27JOHNSON DAVID EDWARDBuy19.13K$50.03957.22K
2026-05-26Aftab DanaSell43.45K$50.352.19M
2026-05-20Haley Patrick J.Sell32.11K$49.811.60M
2026-05-18MORRISSEY MICHAELBuy124.05K——
2026-05-18MORRISSEY MICHAELSell124.05K——
2026-05-18Senner Christopher J.Sell34.90K$50.001.75M
2026-05-18Hefti BrendaSell6.62K$50.21332.64K
2026-05-15MORRISSEY MICHAELSell128.50K$51.106.57M
2026-05-15Senner Christopher J.Sell40.89K$51.102.09M
2026-05-15Haley Patrick J.Sell33.27K$51.101.70M
2026-05-15Hefti BrendaSell6.41K$51.10327.60K
2026-05-15Aftab DanaSell30.58K$51.101.56M
2026-05-07Beckerle Mary CBuy3.86K$23.2489.61K
2026-05-07Beckerle Mary CSell7.71K$48.45373.65K
2026-05-07Beckerle Mary CSell3.86K$23.2489.61K
2026-05-07Freire Maria CBuy20.63K$19.77407.93K
2026-05-07Freire Maria CSell20.63K$46.00949.16K
2026-05-07Freire Maria CSell20.63K$19.77407.93K
2026-05-07POSTE GEORGESell60.00K$45.712.74M
2026-05-06MORRISSEY MICHAELSell109.68K——
2026-02-26Aftab DanaBuy52.02K——
2026-02-26Senner Christopher J.Buy52.02K——
2026-02-26Hefti BrendaBuy23.12K——
2026-02-26Haley Patrick J.Buy40.46K——
2026-02-26MORRISSEY MICHAELBuy160.44K——
2026-02-24MORRISSEY MICHAELSell100.28K——
2026-02-24Aftab DanaSell47.92K$44.502.13M
2026-02-19Aftab DanaSell29.87K$44.351.32M
2026-02-18WYSZOMIERSKI JACK LBuy20.63K$19.77407.93K
2026-02-18WYSZOMIERSKI JACK LSell99.57K$44.014.38M
2026-02-18WYSZOMIERSKI JACK LSell20.63K$19.77407.93K
2026-02-18Smith JulieBuy44.09K$19.39854.85K
2026-02-18Smith JulieBuy20.03K$21.69434.45K
2026-02-18Smith JulieSell44.09K$44.501.96M
2026-02-18Smith JulieSell20.03K$44.30887.33K
2026-02-18Smith JulieSell20.03K$21.69434.45K
2026-02-18Smith JulieSell44.09K$19.39854.85K
2026-02-18MORRISSEY MICHAELBuy125.09K——
2026-02-18MORRISSEY MICHAELSell125.09K——
2026-02-18Hefti BrendaSell18.67K$44.01821.62K
2026-02-17Smith JulieBuy42.42K$18.19771.66K
2026-02-17Smith JulieSell42.42K$43.331.84M
2026-02-17Smith JulieSell42.42K$18.19771.66K
2026-02-17Senner Christopher J.Sell30.62K$43.671.34M
2026-02-17Haley Patrick J.Sell3.04K$43.84133.10K
2026-02-17Haley Patrick J.Sell64.78K$43.502.82M
2026-02-17MORRISSEY MICHAELBuy250.74K——
2026-02-17MORRISSEY MICHAELSell250.74K——
2026-02-15Senner Christopher J.Sell35.87K$43.921.58M
2026-02-15Haley Patrick J.Sell31.48K$43.921.38M
2026-02-15MORRISSEY MICHAELSell120.39K$43.925.29M
2026-02-15Aftab DanaSell26.48K$43.921.16M
2026-02-15Aftab DanaSell12.72K$43.92558.66K
2026-02-15Hefti BrendaSell5.43K$43.92238.49K
2026-02-13Senner Christopher J.Sell34.28K$43.001.47M
2026-02-13MORRISSEY MICHAELBuy494.70K$21.3110.54M
2026-02-13MORRISSEY MICHAELSell369.61K$43.9216.23M
2026-02-13MORRISSEY MICHAELSell494.70K$21.3110.54M
2026-02-13Eckhardt Sue GailSell3.86K$43.79168.85K
2026-02-13Oliver BobBuy9.09K$19.28175.22K
2026-02-13Oliver BobSell9.09K$43.61396.33K
2026-02-13Oliver BobSell21.16K$43.90929.01K
2026-02-13Oliver BobSell9.09K$19.28175.22K
2026-01-15MORRISSEY MICHAELBuy548.07K——
2026-01-15MORRISSEY MICHAELSell139.52K$45.236.31M
2026-01-15Aftab DanaBuy119.58K——
2026-01-15Aftab DanaSell27.25K$45.231.23M
2026-01-15Haley Patrick J.Buy139.51K——
2026-01-15Haley Patrick J.Sell32.33K$45.231.46M
2026-01-15Senner Christopher J.Buy149.47K——
2026-01-15Senner Christopher J.Sell40.46K$45.231.83M
2025-12-03Hefti BrendaBuy30.17K——
2025-11-25JOHNSON DAVID EDWARDBuy27.53K$43.121.19M
2025-11-21Haley Patrick J.Sell28.04K$42.581.19M
2025-11-21Aftab DanaSell24.00K——
2025-11-20Haley Patrick J.Sell10.00K$42.11421.10K
2025-11-20Haley Patrick J.Sell23.54K$41.93986.99K
2025-11-20Haley Patrick J.Sell10.65K$41.77444.77K
2025-11-17Oliver BobSell1.04K——
2025-11-12PAPADOPOULOS STELIOSSell100.00K$43.554.36M
2025-11-12MORRISSEY MICHAELBuy101.55K——
2025-11-12MORRISSEY MICHAELSell80.00K——
2025-11-12MORRISSEY MICHAELSell101.55K——
2025-11-11MORRISSEY MICHAELSell160.00K——
2025-11-11Aftab DanaSell48.38K$42.502.06M
2025-11-11Beckerle Mary CBuy5.78K$23.24134.42K
2025-11-11Beckerle Mary CSell5.78K$42.03243.10K
2025-11-11Beckerle Mary CSell18.84K$41.90789.31K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 779, holders +57 vs prior quarter. Ownership 104.21%.

HolderSharesChangeChange %Value
BLACKROCK, INC.29.08M-1.74M-5.65%1.58B
FARALLON CAPITAL MANAGEMENT, L.L.C.13.47M357.00K+2.72%732.79M
RENAISSANCE TECHNOLOGIES LLC13.43M-299.00K-2.18%730.62M
VANGUARD PORTFOLIO MANAGEMENT LLC12.04M-42.15K-0.35%655.27M
AQR CAPITAL MANAGEMENT LLC11.02M-2.07M-15.82%598.60M
VANGUARD CAPITAL MANAGEMENT LLC10.95M-307.99K-2.74%595.84M
STATE STREET CORP9.97M-328.37K-3.19%542.47M
FULLER & THALER ASSET MANAGEMENT, INC.8.93M387.15K+4.53%485.85M
LSV ASSET MANAGEMENT8.15M400.76K+5.17%443.25M
GEODE CAPITAL MANAGEMENT, LLC7.65M-145.29K-1.86%416.32M
D. E. SHAW & CO., INC.5.55M1.95M+54.08%302.07M
MORGAN STANLEY4.52M341.45K+8.17%245.92M
INVESCO LTD.4.50M181.32K+4.20%244.61M
DIMENSIONAL FUND ADVISORS LP4.43M127.02K+2.95%240.85M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP4.37M-468.70K-9.69%237.55M
TWO SIGMA INVESTMENTS, LP4.21M2.00M+90.82%229.06M
ASSETMARK, INC3.43M44.90K+1.33%186.83M
NUVEEN, LLC3.28M-505.75K-13.37%178.30M
UBS GROUP AG3.17M774.38K+32.35%172.36M
STEPHENS INVESTMENT MANAGEMENT GROUP LLC2.71M185.51K+7.35%147.45M
GOLDMAN SACHS GROUP INC2.69M571.91K+27.00%146.39M
NORGES BANK2.69M2.69MNew146.30M
FIRST TRUST ADVISORS LP2.54M8.36K+0.33%138.38M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.2.26M2.26MNew123.07M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC2.26M-56.42K-2.43%123.07M

Insights

Revenue by product
PeriodValue
FY2017Cabometyx: 324000000.0
FY2018Cabometyx: 599946000.0, Cometriq: 19333000.0, License: 192188000.0, Other Collaboration: 2858000.0, Product: 619279000.0, Product, Gross: 738529000.0, Research and Development: 39501000.0, Sales Discounts And Allowances: 119250000.0
FY2020Cabometyx: 733421000.0, Collaboration: 207825000.0, Collaboration, License: 161299000.0, Collaboration, Other: -3439000.0, Collaboration, Research And Development Service: 49965000.0, Cometriq: 26529000.0, Product: 759950000.0, Product, Gross: 957621000.0, Product, Sales Discounts And Allowances: -197671000.0
FY2021Collaboration: 245988000.0, License: 167295000.0, Product: 741550000.0, Product, Gross: 962591000.0, Product, Sales Discounts And Allowances: -221041000.0, Service: 78693000.0
FY2021Collaboration: 357714000.0, Product: 1077256000.0, Product, Gross: 1452913000.0, Product, Sales Discounts And Allowances: -375657000.0
FY2022Collaboration: 209819000.0, License: 162056000.0, Product: 1401243000.0, Product, Gross: 1951169000.0, Product, Sales Discounts And Allowances: -549926000.0, Service: 47763000.0
FY2023Collaboration: 201329000.0, License: 178635000.0, Product: 1628879000.0, Product, Gross: 2272533000.0, Product, Sales Discounts And Allowances: -643654000.0, Service: 22694000.0
FY2025Collaboration: 359306000.0, License: 349244000.0, Product: 1809395000.0, Product, Gross: 2518246000.0, Product, Sales Discounts And Allowances: -708851000.0, Service: 10062000.0
FY2026Collaboration: 197322000.0, License: 214375000.0, Product: 2122804000.0, Product, Gross: 3011807000.0, Product, Sales Discounts And Allowances: -889003000.0, Service: -17053000.0
Revenue by region
PeriodValue
FY2017Europe: 69792000.0, Rest of World: 14779000.0, UNITED STATES: 367906000.0
FY2018Europe: 182879000.0, Other Geographical Areas: 38020000.0, UNITED STATES: 632927000.0
FY2020Europe: 152771000.0, JAPAN: 44760000.0, UNITED STATES: 770244000.0
FY2021Europe: 151631000.0, JAPAN: 83017000.0, UNITED STATES: 752890000.0
FY2021Europe: 302073000.0, JAPAN: 43501000.0, UNITED STATES: 1089396000.0
FY2022Europe: 168592000.0, JAPAN: 28727000.0, UNITED STATES: 1413743000.0
FY2023Europe: 144969000.0, JAPAN: 39490000.0, UNITED STATES: 1645749000.0
FY2025Europe: 318633000.0, JAPAN: 27076000.0, UNITED STATES: 1822992000.0
FY2026Europe: 154165000.0, JAPAN: 25590000.0, UNITED STATES: 2140371000.0

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Exelixis (EXEL) Stock Insights

EXEL$66.04+0.69 +1.06%

$16.60B

Market Cap

19.86

P/E

18.53

Forward P/E

64

Score

Price History